Medical Science Liaison, Dermatology/Autoimmune Disorders – Alberta/Saskatchewan at Eli Lilly and Company

Alberta, Alberta, Canada

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, HealthcareIndustries

Requirements

  • Advanced scientific knowledge in Dermatology and related autoimmune disorders
  • Ability to maintain technical expertise within the therapeutic area to engage in scientific discussions with scientific experts
  • Compliance with all applicable guidelines, Rules and Regulations for Conducting Research, Rx and D Code of Conduct, Eli Lilly Canada Policy on the Promotion of Pharmaceutical Products, and Ethical Interactions with Health Care Providers, and other prevailing regulations/codes
  • Location in or ability to cover Alberta/Saskatchewan

Responsibilities

  • Serve as a scientific resource for Canadian experts in Dermatology and related autoimmune disorders, responding to requests for in-depth, cutting-edge scientific information including latest scientific literature, research from major conferences, updates on Lilly’s educational activities, and pipeline research
  • Gather feedback and insight from Scientific Experts and Thought Leaders to inform Lilly’s research and strategic direction
  • Facilitate scientific exchange between the academic community and Lilly
  • Develop and maintain mutually beneficial, peer-to-peer relationships with the scientific community, including scientific experts, researchers, educators, and clinical investigators
  • Spend significant time on customer-facing activities, representing Lilly and providing deep disease state and product information
  • Connect thought leaders and scientific experts with Lilly resources (e.g., Discovery, Real World Evidence Scientists, Clinical Research Physicians, Global/Canadian External Research & Development)
  • Effectively communicate with Scientific Experts and Thought Leaders using up-to-date scientific knowledge, responding timely to inquiries with information such as reprints, posters, medical letters, literature citations, access to experts, slides, and teaching materials
  • Continually enhance scientific knowledge in the therapeutic area

Skills

Dermatology
Autoimmune Disorders
Scientific Literature
Conference Research
Pipeline Research
Thought Leader Engagement
Scientific Exchange

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI